Citation Impact
Citing Papers
Excitatory amino acid antagonists for acute stroke
2003
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Antidepressant effects of ketamine in depressed patients
2000 Standout
Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.
1990
Glutamate receptor ion channels
2005 Standout
Inflammation and Alzheimer's disease
2000 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia
1990
Automatic classification of MR scans in Alzheimer's disease
2008 Standout
Cognitive Enhancement Therapy for Alzheimerʼs Disease
1997
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory in rats.
1989
Sign-tracking (autoshaping) in rats: A comparison of cocaine and food as unconditioned stimuli
2004
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)
1995
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
1998
Effect of xanthine derivatives on hippocampal long-term potentiation
1990
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Tactile Devices To Sense Touch on a Par with a Human Finger
2008
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 Standout
Neuroprotection for ischemic stroke: Past, present and future
2008
Nerve Growth Factor Gene Therapy in Alzheimer Disease
2007
Factors That Can Affect the External Validity of Randomised Controlled Trials
2006
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies
2012
Cholinergic improvement of a naturally-occurring memory deficit in the young rat
1996
A synaptic model of memory: long-term potentiation in the hippocampus
1993 StandoutNature
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease
2001
Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
1999
Neurotrophic factor therapy for nervous system degenerative diseases
1994
Flutter Discrimination: neural codes, perception, memory and decision making
2003
Double-blind placebo-controlled study of velnacrine in Alzheimer's disease
1996
Run-in Periods in Randomized Trials
1998
A desensitization‐selective potentiator of AMPA‐type glutamate receptors
2002
Oxidative stress and Alzheimer disease
2000 Standout
Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants
1989
Structural and kinetic features of amyloid β-protein fibrillogenesis
1998
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997
Social amnesia in mice lacking the oxytocin gene
2000 Standout
Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans
2014 Standout
Tacrine
1995
Alzheimer's disease
2006 Standout
NMDA receptor antagonists as analgesics: focus on the NR2B subtype
2001
Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection
1998
Arisugacins, selective acetylcholinesterase inhibitors of microbial origin
1997 StandoutNobel
Tacrine: A pharmacological review
1991
Alzheimer's Disease
2010 Standout
Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial
1994
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Clinical Trials in Cognitively Impaired Older Adults: Home versus Clinic Assessments
1995
Alzheimer's Disease
2004 Standout
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
1998
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Mild cognitive impairment as a diagnostic entity
2004 Standout
Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders
2004
Cholinesterase Inhibitors for Alzheimer??s Disease
2001
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease
2000
Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease
1997
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
The Nitric Oxide Hypothesis of Migraine and Other Vascular Headaches
1995
Confirmation, disconfirmation, and information in hypothesis testing.
1987 Standout
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
1994
Exercise and Physical Activity for Older Adults
2009 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Nimodipine in the Treatment of Probable Alzheimerʼs Disease
1996
A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
1994
Control of complex, sequential operants by systematic visual information in pigeons.
1981
Effectiveness and Safety of Velnacrine for the Treatment of Alzheimer's Disease
1995
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Orofacial and somatic responses elicited by lithium-, nicotine- and amphetamine-paired sucrose solution
1986
Safety and Tolerability Study of Aptiganel Hydrochloride in Patients With an Acute Ischemic Stroke
1999
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
1997
Physical Activity and Public Health in Older Adults
2007 Standout
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
1994
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Flip and Flop: A Cell-Specific Functional Switch in Glutamate-Operated Channels of the CNS
1990 StandoutScienceNobel
Alzheimer'S Disease: Advances In Genetics, Molecular And Cellular Biology
2007
Emerging Targets in Photopharmacology
2016 StandoutNobel
Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study
1996
Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse
2001 Standout
The Neuropsychiatric Inventory
1997 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Taste reactivity as a dependent measure of the rapid formation of conditioned taste aversion: A tool for the neural analysis of taste-visceral associations.
1988
25th Anniversary Article: The Evolution of Electronic Skin (E‐Skin): A Brief History, Design Considerations, and Recent Progress
2013 Standout
Works of E. Gamzu being referenced
Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents
1982
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
1992
Importance of Temporal Cues for Tactile Spatial- Frequency Discrimination
2001
Pavlovian Control Of Operant Behavior: An Analysis Of Autoshaping And Its Implications For Operant Conditioning
1977
A Pharmacological Perspective of Drugs Used in Establishing Conditioned Food Aversionsa
1985
Therapeutic trials using tacrine and other cholinesterase inhibitors.
1990
Pharmacological effects of the non‐competitive NMDA antagonist CNS 1102 in normal volunteers.
1994